Thursday, May 30, 2019

Natco Pharma settles patent litigation with Onyx Therapeutics over cancer drug

Natco Pharma settles patent litigation with Onyx Therapeutics over cancer drug The company said it has reached a settlement agreement with Onyx Therapeutics Inc related to generic versions of 10mg, 30mg and 60mg of Kyprolis.

from Moneycontrol Business News http://bit.ly/2Kc0mlT
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

US stock: S&P 500 ends lower as investors weigh data, Middle East tensions

The S&P 500's streak came to an end, falling from its peak as weaker retail sales suggested caution among consumers. Despite a stron...